These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35306154)

  • 1. Genetic variation within the human papillomavirus type 16 genome is associated with oropharyngeal cancer prognosis.
    Lang Kuhs KA; Faden DL; Chen L; Smith DK; Pinheiro M; Wood CB; Davis S; Yeager M; Boland JF; Cullen M; Steinberg M; Bass S; Wang X; Liu P; Mehrad M; Tucker T; Lewis JS; Ferris RL; Mirabello L
    Ann Oncol; 2022 Jun; 33(6):638-648. PubMed ID: 35306154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
    Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of the diversity of human papillomavirus 16 variants and L1 antigenic regions relevant for the prevention of human papillomavirus-related oropharyngeal cancer in Japan.
    Yoshida T; Ogawa T; Nakanome A; Ohkoshi A; Ishii R; Higashi K; Ishikawa T; Katori Y; Furukawa T
    Auris Nasus Larynx; 2022 Dec; 49(6):1033-1041. PubMed ID: 35491282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival advantage in patients with human papillomavirus-driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000.
    Whitmarsh A; Pring M; Thomas SJ; Waylen A; Ness AR; Dudding T; Pawlita M; Brenner N; Waterboer T; Schroeder L
    Cancer; 2021 Jul; 127(14):2442-2452. PubMed ID: 33721332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium.
    Robbins HA; Ferreiro-Iglesias A; Waterboer T; Brenner N; Nygard M; Bender N; Schroeder L; Hildesheim A; Pawlita M; D'Souza G; Visvanathan K; Langseth H; Schlecht NF; Tinker LF; Agalliu I; Wassertheil-Smoller S; Ness-Jensen E; Hveem K; Grioni S; Kaaks R; Sánchez MJ; Weiderpass E; Giles GG; Milne RL; Cai Q; Blot WJ; Zheng W; Weinstein SJ; Albanes D; Huang WY; Freedman ND; Kreimer AR; Johansson M; Brennan P
    J Clin Oncol; 2022 Nov; 40(31):3613-3622. PubMed ID: 35700419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx.
    Dahlstrom KR; Anderson KS; Cheng JN; Chowell D; Li G; Posner M; Sturgis EM
    Clin Cancer Res; 2015 Jun; 21(12):2861-9. PubMed ID: 26078432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status.
    Anderson KS; Dahlstrom KR; Cheng JN; Alam R; Li G; Wei Q; Gross ND; Chowell D; Posner M; Sturgis EM
    Oral Oncol; 2015 Jul; 51(7):662-7. PubMed ID: 25957822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of oropharyngeal cancer survival in Europe.
    Anantharaman D; Billot A; Waterboer T; Gheit T; Abedi-Ardekani B; Lagiou P; Lagiou A; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Polesel J; Simonato L; Alemany L; Mena Cervigon M; Macfarlane TV; Znaor A; Thomson PJ; Robinson M; Canova C; Conway DI; Wright S; Healy CM; Toner ME; Pawlita M; Tommasino M; Brennan P
    Oral Oncol; 2018 Jun; 81():89-94. PubMed ID: 29884419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of oral HPV DNA, oral HPV mRNA and circulating tumor HPV DNA in the detection of HPV-related oropharyngeal cancer and cancer of unknown primary.
    Tanaka H; Suzuki M; Takemoto N; Fukusumi T; Eguchi H; Takai E; Kanai H; Tatsumi M; Horie M; Takenaka Y; Yachida S; Inohara H
    Int J Cancer; 2022 Jan; 150(1):174-186. PubMed ID: 34486724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated With Persistence and Clearance of High-Risk Oral Human Papillomavirus (HPV) Among Participants in the HPV Infection in Men (HIM) Study.
    Bettampadi D; Sirak BA; Abrahamsen ME; Reich RR; Villa LL; Ponce EL; Giuliano AR
    Clin Infect Dis; 2021 Nov; 73(9):e3227-e3234. PubMed ID: 33173937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of HPV16-L1 antibody but not HPV16 DNA load or integration predict oropharyngeal patient outcome: The Papillophar study.
    Prétet JL; Dalstein V; Touzé A; Beby-Defaux A; Soussan P; Jacquin É; Birembaut P; Clavel C; Mougin C; Rousseau A; Lacau Saint Guily J;
    Clin Exp Med; 2023 Feb; 23(1):87-96. PubMed ID: 35199231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Antibodies to HPV16 Early Proteins Warrant Investigation as Potential Biomarkers for Risk Stratification and Recurrence of HPV-Associated Oropharyngeal Cancer.
    Fakhry C; Qualliotine JR; Zhang Z; Agrawal N; Gaykalova DA; Bishop JA; Subramaniam RM; Koch WM; Chung CH; Eisele DW; Califano J; Viscidi RP
    Cancer Prev Res (Phila); 2016 Feb; 9(2):135-41. PubMed ID: 26701665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment.
    Zhang Y; Waterboer T; Haddad RI; Miles BA; Wentz A; Gross ND; Fakhry C; Quon H; Lorch JH; Gourin CG; Clayburgh D; Misiukiewicz KJ; Richmon JD; Andersen PE; Posner MR; D'Souza G
    Oral Oncol; 2017 Apr; 67():77-82. PubMed ID: 28351584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.
    Varier I; Keeley BR; Krupar R; Patsias A; Dong J; Gupta N; Parasher AK; Genden EM; Miles BA; Teng M; Bakst RL; Gupta V; Misiukiewicz KJ; Chiao EY; Scheurer ME; Laban S; Zhang D; Ye F; Cui M; Demicco EG; Posner MR; Sikora AG
    Head Neck; 2016 Sep; 38(9):1330-7. PubMed ID: 27080140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and distribution of human papillomavirus (HPV) in Luoyang city of Henan province during 2015-2021 and the genetic variability of HPV16 and 52.
    Wang X; Han S; Li X; Wang X; Wang S; Ma L
    Virol J; 2022 Mar; 19(1):37. PubMed ID: 35246180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma.
    Zhang Y; Sturgis EM; Dahlstrom KR; Wen J; Liu H; Wei Q; Li G; Liu Z
    Cancer Res; 2013 Oct; 73(19):5996-6003. PubMed ID: 23928994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer.
    Drake VE; Fakhry C; Windon MJ; Stewart CM; Akst L; Hillel A; Chien W; Ha P; Miles B; Gourin CG; Mandal R; Mydlarz WK; Rooper L; Troy T; Yavvari S; Waterboer T; Brenner N; Eisele DW; D'Souza G
    Cancer; 2021 Apr; 127(7):1029-1038. PubMed ID: 33426652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of HPV16 African variants and quantitative analysis of viral DNA methylation in oropharyngeal squamous cell carcinomas.
    Barbieri D; Nebiaj A; Strammiello R; Agosti R; Sciascia S; Gallinella G; Landini MP; Caliceti U; Venturoli S
    J Clin Virol; 2014 Jul; 60(3):243-9. PubMed ID: 24845262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.